Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock (NQ:RAIN)

0.7611 -0.0111 (-1.44%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

The Past Week's Notable Insider Buys: Continental Resources, Oscar Health, And More ↗

September 18, 2021

With earnings-reporting season over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week.

Via Talk Markets

The Past Week's Notable Insider Buys: Continental Resources, Oscar Health And More ↗

September 18, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. The week's most notable insider buys were at a health...

Via Benzinga

The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More ↗

August 22, 2021

Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,...

Via Benzinga

Earnings Scheduled For August 10, 2021 ↗

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

Rain Therapeutics (RAIN) Q2 2021 Earnings Call Transcript ↗

August 11, 2021

RAIN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Past Week's Notable Insider Buys Include Krispy Kreme, Biotechs, SPACs And More ↗

July 11, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Initial and secondary public offerings enticed insiders to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 25, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 43.23% to $2.65 during Tuesday's regular session. As of 12:30 EST, Pieris Pharmaceuticals's...

Via Benzinga

42 Stocks Moving In Tuesday's Mid-Day Session ↗

May 25, 2021

Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year's...

Via Benzinga

54 Biggest Movers From Yesterday ↗

May 26, 2021

Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended...

Via Benzinga

42 Stocks Moving In Tuesday's Mid-Day Session ↗

May 18, 2021

Gainers Agenus Inc. (NASDAQ: AGEN) shares surged 33.4% to $4.35. Bristol-Myers Squibb Co and Agenus entered into a global exclusive license agreement, under which Bristol Myers...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021 ↗

May 18, 2021

Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,...

Via Benzinga

Opening Day: E-Commerce Company Global-e Valued At $3.6b In Debut ↗

May 16, 2021

Global-e Online opened 3% below its IPO price before trading higher on Wednesday. Shares of the cross-border e-commerce platform rose as much as 1% in their Nasdaq debut, giving Global-e a market...

Via Talk Markets

Topics Initial Public Offering

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off ↗

May 15, 2021

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the...

Via Benzinga

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗

May 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...

Via Benzinga

Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More ↗

May 02, 2021

Here are some of the most noteworthy insider purchases that were reported in the past week.

Via Talk Markets

Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More ↗

May 02, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders took advantage of recent public...

Via Benzinga

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.